跳至主要内容
临床试验/NCT02935842
NCT02935842已完成不适用

Effectiveness of High-frequency Specific Speech Therapy on Verbal Fluency Decline and/ or Verbal Apraxia in Patients With Parkinson's Disease With and Without Deep Brain Stimulation (DBS) - a Randomized Controlled Single-blinded Trial

University Hospital, Basel, Switzerland2 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2016年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
38
试验地点
2
主要终点
Velocity in Gait

研究概览

简要总结

Due to Parkinson's Disease (PD) speech and language (SL) deficits may occur. Further, the literature reports that PD patients, who have not undergone deep brain stimulation (DBS), have deficits regarding voice quality (e.g. loudness and intelligibility of their voice), while PD patients who have undergone DBS suffer from deficits in word retrieval and speech apraxia symptoms. To-date, therapeutic approaches focusing specifically on SL deficits observed in PD-DBS patients are yet to be developed and evaluated.

Therefore, this study investigates the short-and longterm effectiveness of specific and intensive, high-frequency speech-language therapy in terms of reducing SL-deficits compared to a nonspecific and non-verbal sham treatment (i.e. a rhythmic balance-movement training (rBMT)) as well as to a 'no-therapy' condition.

详细描述

In the course of Parkinson's disease (PD) speech and language (SL) deficits may often emerge. In addition, severe verbal fluency (VF) decline has been repeatedly observed in the context of deep brain stimulation (DBS) in PD. Interestingly, while PD non-DBS patients have deficits with respect to loudness and intelligibility of their voice, PD patients who have undergone DBS (PD-DBS) suffer rather from difficulties in semantic and phonemic word retrieval, and from speech apraxia symptoms.

However, to-date and to the best of our knowledge, therapeutic approaches focusing specifically on SL deficits observed in PD-DBS patients are yet to be developed and evaluated regarding their effectiveness. Thus, this study investigates the short-and longterm effectiveness of specific and intensive, high-frequency speech-language therapy in terms of reducing SL-deficits compared to a nonspecific and non-verbal sham treatment (i.e. a rhythmic balance-movement training (rBMT)) as well as to a 'no-therapy' condition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • for all groups:
  • The patient is able to cooperate
  • The patient has the mental competence to provide informed consent to participate in the study
  • The patient speaks and understands German
  • Specific Inclusion Criteria for the DBS Group
  • Fulfilling the above stated inclusion criteria as stated in a, b and c above
  • The patient is responsive to Levodopa (L-DOPA)
  • Having received or being scheduled for DBS

排除标准

  • Severe psychiatric disease difficult to treat (compulsive disorder, depression, mania, psychosis, anxiety as outlined in International Classification of Diseases (ICD-10) (WHO 2015, current version).
  • Patient with dementia (DMS-V, Mini-Mental-Status-Test (MMS) <24, Montreal Cognitive Assessment (MoCa) <21)
  • Secondary Parkinsonism
  • Age ≤18 years
  • Pregnancy (early onset)
  • Presence of a known disease other than PD that shortens the life expectancy
  • Mental incompetence to provide informed consent to participate in the study
  • Previous intracranial surgery
  • Contraindications for DBS seen in MRI-scan (malignant tumour, severe microvascular disease)
  • Insufficient skills of German language for participating in neuropsychological evaluations
  • Sensory problems, severe enough to significantly interfere with neuropsychological assessment
  • Alcohol and/or drug addiction

结局指标

主要结局

Velocity in Gait

时间窗: At Baseline (BL), T1 after 4 weeks (4W-directly after intervention), T2 after 6 months (6M).

Gait Velocity: meters per second

Cadence in Gait

时间窗: At Baseline (BL), T1 after 4 weeks (4W-directly after intervention), T2 after 6 months (6M).

4-Weeks and 6-Months Follow-up. To measure rhythmicity in gait, participants walked 6 metres at their individual pace. They were timed and amount of steps were counted.

Speech Velocity

时间窗: At Baseline (BL), T1 after 4 weeks (4W-directly after intervention), T2 after 6 months (6M).

Speech Velocity at 4 weeks and at 6 months To measure rhythmicity in speech, participants read a text aloud ('the north wind and the sun') and were recorded using an Olympus. According to these speech samples, the count of elicited syllables per second was calculated.

Speech Cadence

时间窗: At Baseline (BL), T1 after 4 weeks (4W-directly after intervention), T2 after 6 months (6M).

Speech Cadence 4 Weeks and at 6 Months To measure rhythmicity in speech, participants' speech was recorded while reading a text aloud ('the north wind and the sun'). Elicited syllables per inspiration were analysed.

次要结局

  • Neuropsychiatric Self-rating Questionnaires(At 4 Weeks and 6 Months)
  • Health Status (UPDRS)(At Baseline and 6 Months)
  • Neuropsychological Standardised Test Battery(At 4 Weeks and at 6 Months)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验